MGMT and central nervous system cancer: One example is the promoter methylation of the gene MGMT (O-6-methylguanine-DNA methyltransferase), coding for a DNA repair enzyme, which was shown to increase sensitivity to drugs such as carmustine and temozolomide in gliomas (Esteller et al., 2000; Hegi et al., 2005).